within Pharmacolibrary.Drugs.ATC.C;

model C07FX01
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.26,
    Cl             = 0.021666666666666667,
    adminDuration  = 600,
    adminMass      = 0.08,
    adminCount     = 1,
    Vd             = 0.0043,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.009666666666666665,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Propranolol is a non-selective beta-adrenergic blocker used primarily to manage hypertension, angina pectoris, cardiac arrhythmias, and in some cases, migraine prophylaxis and anxiety. The ATC code C07FX01 refers to propranolol and its various fixed-dose combinations with other cardiovascular agents, mainly for hypertension and heart disease. Propranolol remains an approved and widely used medication today.</p><h4>Pharmacokinetics</h4><p>Population pharmacokinetics of propranolol and its fixed-dose combinations in healthy adults, typical oral dose range. Parameters are given as mean values reported in published reference.</p><h4>References</h4><ol><li>Zeping Hu, Xiaoxia Yang, Paul Chi Lui Ho, Sui Yung Chan, Paul Wan Sia Heng, Eli Chan, Wei Duan, Hwee Ling Koh, Shufeng Zhou,Herb-drug interactions: a literature review.,Drugs,2005<a href='https://pubmed.ncbi.nlm.nih.gov/15916450/'>https://pubmed.ncbi.nlm.nih.gov/15916450/</a></li><li>Neha Saini, Bhawna Chopra, Ashwani K Dhingra,Synergistic Effect of Piperine and its Derivatives: A Comprehensive Review.,Current drug research reviews,2023<a href='https://pubmed.ncbi.nlm.nih.gov/36321239/'>https://pubmed.ncbi.nlm.nih.gov/36321239/</a></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end C07FX01;
